Page last updated: 2024-11-05

xylazine and Hearing Loss

xylazine has been researched along with Hearing Loss in 1 studies

Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.

Hearing Loss: A general term for the complete or partial loss of the ability to hear from one or both ears.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mülazımoğlu, S1
Ocak, E1
Kaygusuz, G1
Gökcan, MK1

Other Studies

1 other study available for xylazine and Hearing Loss

ArticleYear
Retroauricular Approach for Targeted Cochlear Therapy Experiments in Wistar Albino Rats.
    Balkan medical journal, 2017, May-05, Volume: 34, Issue:3

    Topics: Anesthesia; Anesthetics, Dissociative; Animals; Blister; Cochlea; Hearing Loss; Hypnotics and Sedati

2017